Mativ Holdings, Inc. · NYSE:MATV
Mativ — Schweitzer Mauduit International — Merger or Acquisition (January 2021)
12 slides from Mativ's merger presentation, Jan 27, 2021
Slide 1: Recommended Cash Offer for Scapa Group plc
© 2021 Schweitzer - Mauduit International, Inc. RECOMMENDED CASH OFFER FOR SCAPA GROUP PLC Best - In - Class Innovation, Design, & Manufacturing Solutions For Healthcare & Industrial Markets January 2021
Slide 2: Forward-looking statements
© 2021 Schweitzer - Mauduit International, Inc. This presentation may contain “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , federal securities laws, and other applicable laws, that are subject to the safe harbor created by such laws and o
Slide 3: Restrictions on certain information under the UK Takeover Code
© 2021 Schweitzer - Mauduit International, Inc. Restrictions on certain information under the UK Panel on Takeovers and Mergers Scapa Group plc (“ Scapa ”) is a company subject to the jurisdiction of the UK Panel on Takeovers and Mergers and the City Code on Takeovers and Mergers (the “Code”) . Unde
Slide 4: Enhancement of SWM's growth profile with Scapa
© 2021 Schweitzer - Mauduit International, Inc. Exciting enhancement of SWM’s growth profile with a scaled “full solution” Medical materials platform and complementary Industrial products portfolio Scapa Overview (LSE: SCPA ) • Significant capabilities and scale in value - added integrated solutions
Slide 5: Scapa Business Overview: Integrated Solutions Model
© 2021 Schweitzer - Mauduit International, Inc. Integrated Solutions Model : Large medical OEMs trust Scapa as a development and production partner, utilizing Scapa’s material sciences and converting expertise to solve their products’ design and application challenges… “sticky” relationships, contra
Slide 6: Scapa Healthcare triples SWM's medical business
© 2021 Schweitzer - Mauduit International, Inc. “Medical device companies are rethinking their integrated model and shifting towards an asset - light strategy and looking to external partners to fill the gap in development, supply chain and manufacturing.” – Scapa annual report Scapa Healthcare oper
Slide 7: Specialty Healthcare Applications
© 2021 Schweitzer - Mauduit International, Inc. • Broad set of products designed to heal • Typically used in hospital and outpatient settings for dressings and topical skincare solutions • Innovative formulations and range of substrates Advanced Woundcare Device Fixation for Wearables • Medical devi
Slide 8: Specialty Industrial Applications
© 2021 Schweitzer - Mauduit International, Inc. Moisture barriers, electrical wiring, HVAC; temperature - resistant bonding and adherence to strict codes are critical Construction Automotive Cable Consumer Power, sub - sea, data and fiber - optic cables Parts assembly, body construction, trim, mirro
Slide 9: Synergies and Portfolio Growth
© 2021 Schweitzer - Mauduit International, Inc. Scapa has an attractive standalone business; however, we see meaningful strategic and financial opportunities for the combined businesses Together we expect to drive enhanced long - term growth for SWM • Further diversifies our balanced portfolio of at
Slide 10: Strategic Fit – Strengthening the Portfolio
© 2021 Schweitzer - Mauduit International, Inc. Current Markets / Technologies Filtration Construction Transportation Industrial Medical Tobacco New End - Markets Nets x x x x Films x x x x Fibers/Paper x x x Non - Wovens x x x Coatings & Converting x x x x New Technologies Similar assets & technolo
Slide 11: Financial Overview of Transaction
© 2021 Schweitzer - Mauduit International, Inc. Financial Overview of Transaction 11 Transaction Value* Approximately $551.9 million (£402.9 million)* , offering $2.877 (£2.10) / share of Scapa (18.6% premium) Financing Transaction financed by way of an upsizing of SWM’s existing syndicated debt fac
Slide 12: Visit us at swmintl.com
© 2021 Schweitzer - Mauduit International, Inc. Visit us at swmintl.com 12
Schweitzer Mauduit International — Merger or Acquisition (January 2021) on 6ix